ERBB2 and colorectal carcinoma: Specifically, we observed a striking enrichment in BRAFV600E and RTK fusions in MSI-H CRC patients, while KRASG12C mutation and ERBB2 amplification only occurred in MSS CRC patients, probably due to the mutual exclusion between members of mitogen-activated protein kinase (MAPK) family.